AR020067A1 - Uso y composicion para inducir una respuesta anti-tumoral contra una metastasis de melanoma - Google Patents
Uso y composicion para inducir una respuesta anti-tumoral contra una metastasis de melanomaInfo
- Publication number
- AR020067A1 AR020067A1 ARP990101625A ARP990101625A AR020067A1 AR 020067 A1 AR020067 A1 AR 020067A1 AR P990101625 A ARP990101625 A AR P990101625A AR P990101625 A ARP990101625 A AR P990101625A AR 020067 A1 AR020067 A1 AR 020067A1
- Authority
- AR
- Argentina
- Prior art keywords
- cell
- melanoma
- composition
- membrane
- tumor response
- Prior art date
Links
- 201000001441 melanoma Diseases 0.000 title abstract 8
- 230000006023 anti-tumor response Effects 0.000 title abstract 4
- 206010027476 Metastases Diseases 0.000 title abstract 3
- 230000009401 metastasis Effects 0.000 title abstract 3
- 210000004027 cell Anatomy 0.000 abstract 8
- 239000012528 membrane Substances 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 2
- 210000004072 lung Anatomy 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010027480 Metastatic malignant melanoma Diseases 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000001394 metastastic effect Effects 0.000 abstract 1
- 208000021039 metastatic melanoma Diseases 0.000 abstract 1
- 206010061289 metastatic neoplasm Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/876—Skin, melanoma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8125698P | 1998-04-09 | 1998-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR020067A1 true AR020067A1 (es) | 2002-04-10 |
Family
ID=22163059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990101625A AR020067A1 (es) | 1998-04-09 | 1999-04-09 | Uso y composicion para inducir una respuesta anti-tumoral contra una metastasis de melanoma |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1067960A2 (de) |
| JP (1) | JP2003524583A (de) |
| CN (1) | CN1301174A (de) |
| AR (1) | AR020067A1 (de) |
| AU (1) | AU3482199A (de) |
| CA (1) | CA2327339A1 (de) |
| PL (1) | PL366240A1 (de) |
| WO (1) | WO1999052546A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000057911A2 (en) | 1999-03-16 | 2000-10-05 | Thomas Jefferson University | Hapten-conjugated mammalian cells and methods of making and using thereof |
| JP2004507446A (ja) * | 2000-02-04 | 2004-03-11 | トーマス・ジェファーソン・ユニバーシティ | 低用量ハプテン化腫瘍細胞および腫瘍細胞抽出物の免疫治療 |
| US7297330B2 (en) | 2000-02-04 | 2007-11-20 | Thomas Jefferson University | Low dose haptenized tumor cell and tumor cell extract immunotherapy |
| WO2003103389A2 (en) | 2002-06-10 | 2003-12-18 | Avax Technologies Inc. | Cryopreservation of haptenized tumor cells |
| FR3011850B1 (fr) * | 2013-10-15 | 2018-04-06 | Cfl Biotech | Vaccin therapeutique contre le cancer a base de proteines de stress rendues immunogenes |
| GB2630768B (en) * | 2023-06-07 | 2025-07-02 | Alv B As | Administration of bacterial composition for use in treatment of lung metastases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2302337T3 (es) * | 1995-06-07 | 2008-07-01 | Thomas Jefferson University | Extracto de celulas tumorales modificadas con hapteno y procedimientos para tratar cancer. |
| PL328790A1 (en) * | 1996-10-04 | 1999-02-15 | Univ Jefferson | T-lymphocytes provoking an immunological response and methods of using them |
| AU2686999A (en) * | 1998-02-17 | 1999-08-30 | Thomas Jefferson University | Hapten-modified tumor cell membranes, and methods of making and using hapten-modified tumor cell membranes |
-
1999
- 1999-04-09 AR ARP990101625A patent/AR020067A1/es unknown
- 1999-04-09 EP EP99916518A patent/EP1067960A2/de not_active Withdrawn
- 1999-04-09 CN CN99806236A patent/CN1301174A/zh active Pending
- 1999-04-09 JP JP2000543156A patent/JP2003524583A/ja active Pending
- 1999-04-09 PL PL99366240A patent/PL366240A1/xx unknown
- 1999-04-09 AU AU34821/99A patent/AU3482199A/en not_active Abandoned
- 1999-04-09 WO PCT/US1999/007725 patent/WO1999052546A2/en not_active Ceased
- 1999-04-09 CA CA002327339A patent/CA2327339A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999052546A3 (en) | 1999-12-16 |
| CA2327339A1 (en) | 1999-10-21 |
| PL366240A1 (en) | 2005-01-24 |
| CN1301174A (zh) | 2001-06-27 |
| AU3482199A (en) | 1999-11-01 |
| EP1067960A2 (de) | 2001-01-17 |
| WO1999052546A2 (en) | 1999-10-21 |
| JP2003524583A (ja) | 2003-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2104072T3 (es) | Redistribucion de composiciones de policarbonato organico. | |
| DE69941713D1 (de) | Abstammungs-spezifische zellen und vorläuferzellen | |
| ES260079A1 (es) | Procedimiento para tenir el cabello | |
| ES2059207T3 (es) | Procedimiento para la preparacion de derivados del taxano, nuevos derivados obtenidos y composiciones farmaceuticas que les contienen. | |
| UY27069A1 (es) | Activadores de glucocinasa del tipo isoindolin-1-ona | |
| MX2010003110A (es) | Composiciones de polipeptido de elemento nuclear intercalado largo y metodos de uso de las mismas. | |
| ES2175462T3 (es) | Composiciones cristalizables que comprenden un complejo del dominio de proteasa ns3 del virus de la hepatitis c/ns4a, y cristales asi obtenidos. | |
| GT201000037A (es) | Depsipéptidos cíclicos | |
| ATE339963T1 (de) | Tamandarin und didemnin analoga und methoden zu deren herstellung und verwendung | |
| AR067980A1 (es) | Peptidos de cdh3 y agentes que los comprenden | |
| DK1392335T3 (da) | Farmaceutisk og/eller kosmetisk sammensætning til behandling af lokal adipositas og cellulite | |
| AR020067A1 (es) | Uso y composicion para inducir una respuesta anti-tumoral contra una metastasis de melanoma | |
| GT200800307A (es) | 18-metil-19-nor-androst-4-en-17,17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas), asi como preparaciones farmaceuticas que los contienen | |
| AR246160A1 (es) | Preservativo para composiciones acuosas. | |
| PA8577701A1 (es) | Polipeptido t20 pegilado | |
| ES8900046A1 (es) | Un procedimiento para la preparacion de epipodofilotoxina | |
| ECSP034532A (es) | Derivados del 1-aminobutan-3-ol sustituido | |
| DK578887D0 (da) | Antihypertensiva | |
| AR034065A1 (es) | Productos capilares que contienen aceites naturales con esteroles y acidos grasos insaturados y empleo de aceites naturales y de preparaciones | |
| MX9307203A (es) | COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS. | |
| ES2172967T3 (es) | Metilciclotetradec-5-en-1-ona. | |
| CO5680457A2 (es) | Moleculas de union de nogo-a y uso farmaceutico de las mismas | |
| ES2161643B1 (es) | Mejoras en la patente principal numero 9900887 " procedimiento para la obtencion y refuerzo de laminas de piedra natural de pequeño espesor. | |
| GT200600106A (es) | Agentes endoparasiticidas | |
| UY26307A1 (es) | Las rutas sintéticas eficientes para la preparación de los inhibidores de la proteasa del rinovirus y los intermedios claves |